Pancreatic enzyme supplements and vitamins in cystic fibrosis

被引:4
|
作者
Leonard, CH [1 ]
Knox, AJ [1 ]
机构
[1] CITY HOSP NOTTINGHAM, NHS TRUST, DEPT RESP MED, NOTTINGHAM NG5 1PB, ENGLAND
关键词
cystic fibrosis; pancreatic enzyme replacement therapy; vitamin therapy;
D O I
10.1046/j.1365-277X.1997.00486.x
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The management of pancreatic insufficiency and the maintenance of satisfactory fat-soluble vitamin status are major issues in the nutritional management of cystic fibrosis (CF). This article discusses the pancreatic enzyme replacement preparations currently used in the United Kingdom. It also provides an overview of the importance of fat-soluble vitamins in CF, the supplements currently used, and assesses where future research might be directed. We conclude that dietitians play an important role in helping CF patients to achieve optimal growth and nutritional status, and should therefore be involved in management from diagnosis. Monitoring of pancreatic enzyme replacement therapy (PERT) and vitamin therapy is an integral part of the dietetic assessment, and should be carried out on a regular basis to ensure optimal nutritional management for each individual. Future research needs to concentrate on the efficacy and safety of high lipase enzyme preparations. Research is required to assess the absorption, metabolism and losses of fat-soluble vitamins amongst today's CF population, and to determine requirements according to age group.
引用
收藏
页码:3 / 16
页数:14
相关论文
共 50 条
  • [31] Nutritional supplements in cystic fibrosis
    Kappler, M
    Griese, M
    BRITISH MEDICAL JOURNAL, 2006, 332 (7542): : 618 - 619
  • [32] COMPARATIVE TRIAL OF MEASURES TO PREVENT ACID-PEPTIC INACTIVATION OF PANCREATIC-ENZYME SUPPLEMENTS IN PANCREATIC INSUFFICIENCY DUE TO CYSTIC-FIBROSIS
    SHEPHERD, RW
    GOW, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (01): : 106 - 106
  • [33] PANCREATIC-ENZYME SUPPLEMENT DOSAGE IN CYSTIC-FIBROSIS
    OWEN, G
    PETERS, TJ
    DAWSON, S
    GOODCHILD, MC
    LANCET, 1991, 338 (8775): : 1153 - 1153
  • [34] Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review)
    Somaraju, U. R.
    Solis-Moya, A.
    PAEDIATRIC RESPIRATORY REVIEWS, 2015, 16 (02) : 108 - 109
  • [35] Pancreatic enzyme replacement therapy for young cystic fibrosis patients
    Munck, Anne
    Duhamel, Jean-Francois
    Lamireau, Thierry
    Le Luyer, Bernard
    Le Tallec, Claire
    Bellon, Gabriel
    Roussey, Michel
    Foucaud, Pierre
    Ginies, Jean Louis
    Houzel, Anne
    Marguet, Christophe
    Guillot, Marcel
    David, Valerie
    Kapel, Nathalie
    Dyard, Francois
    Henniges, Friederike
    JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (01) : 14 - 18
  • [36] Community Perspective on Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
    Borowitz, Drucy
    Brooks, Joan Finnegan
    Aliaj, Enid
    Gallotto, Danielle
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (05): : E94 - E97
  • [37] Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines
    Anthony, H
    Collins, CE
    Davidson, G
    Mews, C
    Robinson, P
    Shepherd, R
    Stapleton, D
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1999, 35 (02) : 125 - 129
  • [38] Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis
    Walkowiak, J
    Lisowska, A
    JOURNAL OF PEDIATRICS, 2005, 147 (06): : 870 - 871
  • [39] Daily variability of pancreatic enzyme dose in cystic fibrosis patients
    Walkowiak, Jaroslaw
    Splawska, Irmina
    Lisowska, Aleksandra
    Korzeniewska, Aleksandra
    Stelmach, Iwona
    Cichy, Wojciech
    Przyslawski, Juliusz
    PRZEGLAD GASTROENTEROLOGICZNY, 2007, 2 (01): : 33 - 37
  • [40] Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis
    Ng, Christabella
    Major, Giles
    Smyth, Alan R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):